NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Prescribing
  • Key to symbols

4 Central nervous system

4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder

Total Formulary
ATOMOXETINE (capsules, oral solution)

Restrictions: Restricted to specialist initiation for the treatment of ADHD in the patient groups listed below. In addition, the oral solution is restricted to use in patients who are unable to swallow capsules.

Prescribing Notes:

  • In children over 6 years and adolescents who do not respond to stimulants or in whom stimulants are contraindicated or not tolerated (See GGC Paediatric Formulary).
  • In adults as part of a comprehensive treatment programme.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/128405.htm

DEXAMPHETAMINE

Restrictions: Restricted to second line therapy for the treatment of ADHD and initiation by child or adolescent psychiatrists or paediatricians with expertise in ADHD.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/3374.htm

GUANFACINE HYDROCHLORIDE (INTUNIV) (tablets)

Restrictions: Restricted to specialist initiation for use in ADHD as part of a comprehensive treatment programme only where stimulants are not suitable, not tolerated or have been ineffective.

LISDEXAMFETAMINE (ELVANSE ADULT) (capsules)

Restrictions: Restricted to specialist initiation as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in adults.

BNF Link: https://www.medicinescomplete.com/mc/bnf/current/PHP33124-elvanse.htm?q=elvanse&t=search&ss=text&p=1#PHP33124-elvanse

METHYLPHENIDATE

Restrictions: Restricted to initiation by child or adolescent psychiatrists or paediatricians with expertise in ADHD. The modified-release preparations are restricted to second line therapy where there is evidence of compliance problems or where clear evidence that administration of a midday dose is problematic or inappropriate.

Prescribing Notes:

Prescribe modified-release preparations by brand name.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/31967.htm

MODAFINIL

Restrictions: Modafinil is considered Formulary only for its licensed use in the treatment of excessive sleepiness associated with narcolepsy with or without cataplexy. It is not licensed or approprove for excessive daytime sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome or shift work sleep disorder and these indications are non-Formulary

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/68990.htm